Human leukocyte antigen Class II amino acid epitopes susceptibility and progression markers for beryllium hypersensitivity

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 6, 2002, Pages 788-794

  Rossman, Milton D ^a,b   Stubbs, Jose ^a,b   Chung Lee, W H A ^a,b   Argyris, Elias ^a,b   Magira, Eleni ^a,b   Monos, Dimitri ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Genetics; Granuloma; Human; Human leukocyte antigen molecules; Lung

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; DNA; EPITOPE; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; BERYLLIOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; GENE FREQUENCY; HLA TYPING; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0037086022     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.165.6.2104002     Document Type: Article

References (37)

1. Proliferative response of bronchoalveolar lymphocytes to beryllium
2. Immunopathogenesis of chronic beryllium disease
3. Epidemiology of beryllium intoxication
4. Screening blood test identifies subclinical beryllium disease
5. Epidemiology of beryllium sensitization and disease in nuclear workers
6. Chronic beryllium disease prevention program; final rule
7. 3
8. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant
9. Progressive lung dysfunction in pre-clinical beryllium disease
10. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells
11. Identification of pathogenic T cells in patients with beryllium-induced lung disease
12. HLA-DPB1 glutamate 69: A genetic marker of beryllium disease
13. Differential susceptibilities to chronic beryllium disease contributed by different glu-69 HLA-DPB1 and -DPA1 alleles
14. Interaction of genetic and exposure factors in the prevalence of berylliosis
15. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease
16. HLA-DP Allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease
17. The application of oligonucleotide probes to HLA Class II typing of the DRB sub-region
18. HLA-DR gene frequencies in the Japanese population obtained by oligonucleotide genotyping
19. Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes
20. A DRB oligonucleotide typing system defining 50 of 56 DRB alleles
21. HLA-DP2: Self peptide sequences and binding properties
22. Major histocompatibiity locus genetic markers of beryllium sensitization and disease
23. Beryllium sensitivity is linked to HLA-DP genotype
24. Molecular analysis of HLA-DPB1 alleles in idiopathic systemic sclerosis patients and uranium miners with systemic sclerosis
25. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DPβ chain
26. Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes
27. HLA-DPB polymorphisms: glu 69 association with sarcoidosis
28. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis
29. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate β69
30. Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen, Tri r 2
31. T cell repertoire in tuberculosis: Selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease
32. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis
33. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice
34. Complete sequence and gene map of a human major histocompatibility complex
35. The natural history of beryllium sensitization and chronic beryllium disease
36. In vitro reactivities of blood lymphocytes from symptomatic and asymptomatic pigeon breeders to antigen and mitogens
37. Cellular immune response to fractionated avian antigens by peripheral blood mononuclear cells from patients with pigeon breeder's disease